Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SKOKIE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today reported its financial and...
-
SAN DIEGO, March 31, 2026 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ: BCAB or the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic...
-
RENO, Nev., March 31, 2026 (GLOBE NEWSWIRE) -- Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or “the Company”), a pioneer in sustainable battery metals recycling and refining, today announced key...
-
Total AVAX Holdings of Approximately 13,936,000 as of March 31, 2026 Completed 3.3 Million Share Repurchases Under $40 Million Share Repurchase Program WEST PALM BEACH, FL, March 31, 2026 (GLOBE...
-
Company presents strong balance sheet with year-end cash of approximately $20 million and zero debt Revenue up 14.4% year-over-year Ra’anana, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Rail Vision...
-
Nexxen TV: TV for Today provides audience discovery, planning and activation cohesively across linear and CTV, along with specific budget allocations, to meet the needs of advertisers today Further...
-
VyOS 1.5 LTS launches with VPP acceleration, sovereign networking, and unified automation across bare metal, cloud, and edge environments.
-
Transaction Values Carvix at $1.0 Billion Implied Enterprise Value; Combined Company Expected to Trade on Nasdaq MIAMI, FL and LUTZ, FL, March 31, 2026 (GLOBE NEWSWIRE) -- Crown Reserve...
-
IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2...
-
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies...